Michel V. Lévesque

Sphingosine 1-Phosphate Receptor Signaling Establishes AP-1 Gradients to Allow for Retinal Endothelial Cell Specialization.

Lois E. H. Smith, C. Betsholtz, S. Swendeman, 2020, Developmental cell.

Investigating a New Generation of Ribozymes in Order to Target HCV

J. Perreault, D. Lévesque, Michel V. Lévesque, 2010, PloS one.

Engineered high-density lipoprotein particles that chaperone bioactive lipid mediators to combat endothelial dysfunction and thromboinflammation

G. FitzGerald, S. Swendeman, M. Liao, 2022, bioRxiv.

A Conserved Target Site in HIV-1 Gag RNA is Accessible to Inhibition by Both an HDV Ribozyme and a Short Hairpin RNA

J. Perreault, A. Gatignol, R. Ouellette, 2014, Molecular therapy. Nucleic acids.

Development of ribozyme-based gene-inactivations; the example of the hepatitis delta virus ribozyme.

J. Perreault, G. Robichaud, M. Asif-Ullah, 2007, Current gene therapy.

Sphingosine 1-phosphate-regulated transcriptomes in heterogenous arterial and lymphatic endothelium of the aorta

W. Pu, R. Proia, Liqun He, 2019, bioRxiv.

Design and evaluation of clinically relevant SOFA-HDV ribozymes targeting HIV RNA.

J. Perreault, A. Gatignol, Michel V. Lévesque, 2014, Methods in molecular biology.